Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegoprazan Maintenance Therapy for Healed Erosive Esophagitis
NCT04022096Phase 3Completed
- Sponsor
- HK inno.N Corporation
- Start
- Jun 2019
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegoprazan in erosive esophagitis (EE), sponsored by HK inno.N Corporation. Started Jun 2019; status: completed.
02
Drugs
tegoprazan
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on NCT04022096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04022096.